Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $50,568 - $59,437
4,900 Added 5.57%
92,800 $1.08 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $243,210 - $290,884
24,200 Added 37.99%
87,900 $934,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $2,254 - $2,706
200 Added 0.31%
63,700 $760,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $120,149 - $148,645
-13,700 Reduced 17.75%
63,500 $687,000
Q3 2023

Nov 15, 2023

BUY
$9.59 - $11.35 $219,611 - $259,915
22,900 Added 42.17%
77,200 $761,000
Q2 2023

Aug 23, 2023

SELL
$9.02 - $10.29 $209,264 - $238,727
-23,200 Reduced 29.94%
54,300 $541,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $3 Million - $4 Million
-326,200 Reduced 80.8%
77,500 $741,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $2.02 Million - $2.68 Million
231,500 Added 134.44%
403,700 $4.49 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $455,376 - $597,681
53,700 Added 45.32%
172,200 $1.48 Million
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $247,754 - $305,523
-24,900 Reduced 17.36%
118,500 $1.28 Million
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $55,917 - $87,780
5,700 Added 4.14%
143,400 $1.58 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $95,511 - $115,972
-7,900 Reduced 5.43%
137,700 $1.87 Million
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $10,600 - $12,104
800 Added 0.55%
145,600 $2.02 Million
Q2 2021

Aug 06, 2021

BUY
$12.97 - $16.15 $575,868 - $717,059
44,400 Added 44.22%
144,800 $2.1 Million
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $566,703 - $773,118
-41,700 Reduced 29.35%
100,400 $1.42 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $2.03 Million - $2.66 Million
142,100 New
142,100 $2.58 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.